- About Us
Ms. Julia A. Stephanus has been the Chief Commercial Officer of Aratana Therapeutics, Inc. since January 15, 2013. Ms. Stephanus has more than 25 years experience in the pharmaceutical industry, where she is closely involved in the commercial development and launch of breakthrough animal health care drugs such as Rimadyl(R) and Revolution(R). From September 2010 to December 2012, Ms. Stephanus served as a Director of The Global Pet Franchise for Ceva Animal Health, where she oversaw the commercial development of new products as well as global marketing for strategic pet products. In 2006, Ms. Stephanus founded Summit VetPharm, the developer of Vectra, a pet parasiticide product line, and served as its President and Chief Executive Officer until it was acquired by Ceva Animal Health in August 2010. Prior to founding Summit VetPharm, Ms. Stephanus worked in various sales and marketing positions for Pfizer Inc. and its legacy companies, where she had the commercial responsibility for, among other things, the development and global launch of two highly-profitable pet products. Ms. Stephanus received a B.A. from Indiana University and has attended executive education programs at Harvard, Columbia and the Wharton School of Business at the University of Pennsylvania.